about
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.Interventions for hereditary haemochromatosis: an attempted network meta-analysis.The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.External beam radiotherapy for unresectable hepatocellular carcinoma.Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.Barriers to the conduct of randomised clinical trials within all disease areas.Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis.Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.Specific barriers to the conduct of randomised clinical trials on medical devices.Falling giants and the rise of gene editing: ethics, private interests and the public good.Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance.The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts.18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Grave fraudulence in medical device research: a narrative review of the PIN seeding study for the Pinnacle hip system.Randomized clinical trials in dentistry: Risks of bias, risks of random errors, reporting quality, and methodologic quality over the years 1955-2013.Botulinum toxin type A therapy for cervical dystonia.Glucocorticosteroids for people with alcoholic hepatitis.Cochrane in CORR ®: Industry Sponsorship and Research Outcome.Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy.Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.Vitamin D supplementation for chronic liver diseases in adults.Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications.Therapeutic bronchoscopy vs. standard of care in acute respiratory failure: a systematic review.Growth hormone therapy for people with thalassaemia.Determinants of selective reporting: A taxonomy based on content analysis of a random selection of the literature.Medicines Save, Medicines Kill.Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants.Attempts to redefine conflicts of interest.Primary outcome switching among drug trials with and without principal investigator financial ties to industry: a cross-sectional study.Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
P2860
Q30234612-054CBD3A-B677-455E-AB7D-57BB0932D18AQ30399628-5F4153B8-33E9-4183-A125-C3DD1185FFB3Q33898415-9A939EB3-578C-467E-8906-917E9374CFEAQ34681207-E8D19AD3-2AD5-423F-B53A-1F54B67DDE6FQ36299237-98A28BEC-4EBB-43CE-A1C3-D5879BC59D13Q37739398-E9BAAA1B-2745-4398-B3D4-9DCB0BA6F758Q38369293-CF22802B-121B-4B16-854D-76CC01F34B0EQ38736327-9D2561B2-D374-424C-B069-286EF747F9A9Q38737314-FF90DAF0-2477-49D9-B5A5-636D02E0A307Q38738566-21E87932-0482-4A0E-B306-E8ECE2ECC5EEQ38747707-48B6112F-DF9F-411C-B73D-8242957E2BCBQ38794395-D4FE9004-398B-4087-BF41-B8D6A9F9D209Q38833243-6A69A665-164B-4AD0-B370-2E71F07B2FCFQ38867031-41018005-EA9D-48F4-96BD-EA41B66008F9Q38891837-F7FCBF9D-20B0-49E9-9945-2CED0E4768CFQ38912794-6A07DAB4-B7A4-46BA-B445-43AC8DE76A43Q39154027-B936A1D5-A69E-4677-BFEF-065AC90E8E6EQ41109700-64C8DC82-3091-4017-B87E-55E35BC9D23FQ41554464-E3BA7ADB-FAD5-4574-BEE0-2857EB31B14BQ42376739-28873E67-C2AA-4B19-9537-54BD3A5ED220Q44824832-D364A90B-E439-49DC-9486-62DFE01A29C4Q47098319-538F848D-0CF4-4742-BCCB-C615BE5A6FA5Q47209556-9A58CE36-23CB-42DC-A741-CEA9B8E23001Q47234206-2BC661AE-A755-4FA9-BDF6-D097D1ACE7ABQ47259028-5A7B6C77-66B8-4760-B2A4-9E4EBBD07DB0Q47325788-29290274-3CF1-4768-8AD5-DB6629A8CD03Q47548940-C76DE9D2-1953-4A85-B2CC-96F21A5A443FQ47557935-6E2D9191-9FCD-4568-A20C-8E0F78C953B1Q47599452-6CC24AE5-EBA4-4345-A8FB-DC7D88970078Q47607397-BA0A5AFD-D536-4727-8BED-316AB4FE5207Q47663614-1D427758-81E9-4ED3-8DEB-51084F352F91Q47739130-4BBF9FDB-841E-4518-836F-5ECB84DFDDC3Q47750410-2F63F750-715B-4AE6-A58B-2806B59FC2A0Q47969344-AED6E764-9279-48E4-87F2-0A48BC26DA06Q48105455-E10EF99A-4854-4363-A348-C64E8289CBA7Q48108788-E8ED15FF-ADD3-4149-ACE4-EE8EE4BD184AQ48128164-14FB80BC-1FE4-450C-BB20-7B93EA683BD3Q49668259-E7D53D41-E30F-4E2C-8C57-2F5813DBA4F1Q50035929-116DF10C-6EDA-4459-9BC6-FA5F2A99DEB8Q53273929-F5913646-91B9-40D7-A278-F3268816EC8A
P2860
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Industry sponsorship and research outcome.
@ast
Industry sponsorship and research outcome.
@en
Industry sponsorship and research outcome.
@nl
type
label
Industry sponsorship and research outcome.
@ast
Industry sponsorship and research outcome.
@en
Industry sponsorship and research outcome.
@nl
prefLabel
Industry sponsorship and research outcome.
@ast
Industry sponsorship and research outcome.
@en
Industry sponsorship and research outcome.
@nl
P2093
P1476
Industry sponsorship and research outcome.
@en
P2093
Barbara Mintzes
Jeppe B Schroll
Joel Lexchin
P304
P356
10.1002/14651858.MR000033.PUB3
P577
2017-02-16T00:00:00Z